Remove Development Remove Regulation Remove Research Analyst Remove Vaccine
article thumbnail

Professionals and Patients Offer Mixed Views on Retail Pharmacy Chains’ Enthusiasm About Trials

ACRP blog

“With retail pharmacies entering the clinical trial space, investigative sites are left with little information around how this move will affect them or their patients,” says Emily Botto, Senior Research Analyst at the Tufts Center for the Study of Drug Development (CSDD) and a scheduled presenter at the ACRP 2024 conference in Anaheim, Calif.

article thumbnail

Professionals and Patients Offer Mixed Views on Retail Pharmacy Chains’ Enthusiasm About Trials

ACRP blog

“With retail pharmacies entering the clinical trial space, investigative sites are left with little information around how this move will affect them or their patients,” says Emily Botto, Senior Research Analyst at the Tufts Center for the Study of Drug Development (CSDD) and a scheduled presenter at the ACRP 2024 conference in Anaheim, Calif.

article thumbnail

COVID-19 Vaccine Data Not Expected Until November as FDA Releases Guidelines for Emergency Use Authorizations

XTalks

Despite the Operation Warp Speed COVID-19 vaccine program spearheaded by US President Donald Trump, some of the lead runners in the program — including Moderna and Pfizer — say that data from their vaccine trials won’t be available well into November. Trump and the White House did not react favorably to the new FDA rules. SteveFDA.”.